Press Release - Company Data

Allon Receives Court Approval for Proposal and Reorganization
Posted 2013-07-10 09:31NAI Editing
refers to its news release dated May 30, 2013 regarding the proposal (the "Proposal") made by the Company to its creditors pursuant to the Bankruptcy and Insolvency Act (Canada) and the reorganization

Allon Provides Update to its Proposal and Reorganization
Posted 2013-06-07 05:36NAI Editing
refers to its news release dated May 30, 2013 regarding the proposal made by the Company to its creditors pursuant to the Bankruptcy and Insolvency Act (Canada).

Allon Announces the Filing of a Proposal with Creditors and Reorganization
Posted 2013-05-29 23:36NAI Editing
announced today that it has filed a proposal (the "Proposal") pursuant to the Bankruptcy and Insolvency Act (Canada) (the "BIA") with the Official Receiver, naming Deloitte & Touche Inc.

Allon Therapeutics Releases First Quarter 2013 Operating Results
Posted 2013-04-29 10:25NAI Editing
announced that its pivotal clinical trial evaluating its lead product candidate davunetide as a treatment for progressive supranuclear palsy (PSP) failed to demonstrate efficacy in this population.

Allon Reports 2012 Audited Operating Results
Posted 2013-03-27 10:59NAI Editing
today announced its audited operating results for 2012.

Allon Provides Shareholder Update
Posted 2013-02-05 09:29NAI Editing
announced today that its previously announced strategic review has generated a number of different strategic alternatives and opportunities that are being actively evaluated.

Allon Announces PSP Clinical Trial Results
Posted 2012-12-18 05:44NAI Editing
announced today that its pivotal clinical trial evaluating its lead product candidate davunetide as a treatment for progressive supranuclear palsy (PSP) failed to demonstrate efficacy in this populati

The United States, New Zealand & Mexico Issue Patent for New Allon Platform
Posted 2012-12-05 00:14NAI Editing
announced today that the United States, New Zealand and Mexican patent authorities have each issued composition of matter patents for a new family of peptides that the Company believes has the potenti

Allon Selected As Top 10 Partnering Prospect by CNS Experts
Posted 2012-11-29 00:07NAI Editing
was selected as one of the "Top 10 CNS Licensing Prospects" and will present today at the Windhover Therapeutics Area Partnerships (TAP) conference in Boston, MA .  A panel of independent experts

Allon Files Preliminary Shelf Prospectus
Posted 2012-11-22 00:36NAI Editing
has filed a preliminary short form base shelf prospectus (the "Shelf Prospectus") with the securities commissions in each province and territory of Canada (other than Quebec).